aspirin and ramatroban

aspirin has been researched along with ramatroban in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Lindberg, K; Risberg, B; Xia, G1
Albors, M; Bioque, G; Carretero, M; Díaz Ricart, M; Escolar, G; Garrido, M; Ordinas, A1
Cissé-Thiam, M; Drouet, L1
Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K1
Abdelazeem, H; Aljesri, K; Norel, X; Ozen, G; Topal, G; Turkyılmaz, G; Turkyılmaz, S1

Other Studies

5 other study(ies) available for aspirin and ramatroban

ArticleYear
In vitro studies on the effect of thromboxane receptor blockade on platelet deposition on vascular surfaces.
    Thrombosis research, 1994, May-01, Volume: 74, Issue:3

    Topics: Animals; Aorta; Aspirin; Blood Vessel Prosthesis; Blood Vessels; Carbazoles; In Vitro Techniques; Linear Models; Perfusion; Platelet Aggregation Inhibitors; Rabbits; Receptors, Thromboxane; Sulfonamides

1994
Inhibition of platelet-vessel wall interactions by thromboxane receptor antagonism in a human in vitro system: potentiation of antiplatelet effects of aspirin.
    European journal of clinical investigation, 1998, Volume: 28, Issue:7

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Aspirin; Blood Platelets; Carbazoles; Drug Synergism; Endothelium, Vascular; Humans; In Vitro Techniques; Perfusion; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Sulfonamides

1998
[Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor].
    Dakar medical, 1999, Volume: 44, Issue:1

    Topics: Animals; Aspirin; Carbazoles; Fibrinolytic Agents; Guinea Pigs; Male; Mesenteric Arteries; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Sulfonamides; Thrombosis

1999
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles

2004
Comparative study on the effect of aspirin, TP receptor antagonist and TxA
    Life sciences, 2021, Dec-01, Volume: 286

    Topics: Arachidonic Acid; Aspirin; Benzofurans; Carbazoles; Enzyme Inhibitors; Female; Humans; Male; Mammary Arteries; Muscle, Smooth, Vascular; Phenylephrine; Receptors, Prostaglandin; Receptors, Thromboxane; Saphenous Vein; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction

2021